Rigel Pharmaceuticals Long Term Deferred Assets (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

35.46 -1.18 (-3.22%) USD | NASDAQ | Feb 20, 16:00

35.45 -0.01 (-0.03%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	--
Eli Lilly & Co.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade
Catalyst Pharmaceuticals, Inc.	Upgrade